- Home
- ARHS vs NBTX Comparison
ARHS vs NBTX Comparison
Compare ARHS & NBTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ARHS
- NBTX
- Stock Information
- Founded
- ARHS 1986
- NBTX 2003
- Country
- ARHS United States
- NBTX France
- Employees
- ARHS N/A
- NBTX N/A
- Industry
- ARHS Other Specialty Stores
- NBTX Biotechnology: Pharmaceutical Preparations
- Sector
- ARHS Consumer Discretionary
- NBTX Health Care
- Exchange
- ARHS Nasdaq
- NBTX Nasdaq
- Market Cap
- ARHS 1.5B
- NBTX 1.3B
- IPO Year
- ARHS 2021
- NBTX 2020
- Fundamental
- Price
- ARHS $10.36
- NBTX $21.70
- Analyst Decision
- ARHS Buy
- NBTX Strong Buy
- Analyst Count
- ARHS 12
- NBTX 1
- Target Price
- ARHS $11.41
- NBTX $8.00
- AVG Volume (30 Days)
- ARHS 1.8M
- NBTX 133.2K
- Earning Date
- ARHS 11-06-2025
- NBTX 09-30-2025
- Dividend Yield
- ARHS N/A
- NBTX N/A
- EPS Growth
- ARHS N/A
- NBTX N/A
- EPS
- ARHS 0.50
- NBTX N/A
- Revenue
- ARHS $1,335,951,000.00
- NBTX $11,930,711.00
- Revenue This Year
- ARHS $8.57
- NBTX N/A
- Revenue Next Year
- ARHS $7.03
- NBTX $114.97
- P/E Ratio
- ARHS $21.20
- NBTX N/A
- Revenue Growth
- ARHS 4.76
- NBTX N/A
- 52 Week Low
- ARHS $6.61
- NBTX $2.76
- 52 Week High
- ARHS $13.02
- NBTX $30.35
- Technical
- Relative Strength Index (RSI)
- ARHS 45.25
- NBTX 52.12
- Support Level
- ARHS $9.65
- NBTX $23.31
- Resistance Level
- ARHS $10.84
- NBTX $28.51
- Average True Range (ATR)
- ARHS 0.42
- NBTX 2.30
- MACD
- ARHS 0.03
- NBTX -0.74
- Stochastic Oscillator
- ARHS 44.53
- NBTX 24.23
About ARHS Arhaus Inc.
Arhaus Inc is a growing lifestyle brand and omnichannel retailer of premium home furniture. The company offers merchandise in several categories, including furniture, outdoor, lighting, textiles, and decor through its Retail and e-commerce sales channels.
About NBTX Nanobiotix S.A.
Nanobiotix SA is a clinical-stage biotechnology company that has one operating segment, which focuses on developing product candidates that use its proprietary nanotechnology to transform cancer treatment by increasing the efficacy of radiotherapy. The company develops NanoXray products to help patients receiving radiotherapy by magnifying the effect of radiotherapy within tumor cells without increasing the dose to surrounding healthy tissues. Its product candidate is NBTXR3, a preclinical research program for cancer immunotherapies.